Eli Lilly Files 8-K on Debt Issuances

Ticker: LLY · Form: 8-K · Filed: 2024-08-14T00:00:00.000Z

Sentiment: neutral

Topics: debt-issuance, financing, 8-k

Related Tickers: LLY

TL;DR

LLY dropped an 8-K detailing new debt issuances, including $1.625B due 2026 and $1.125B due 2051.

AI Summary

Eli Lilly and Company (LLY) filed an 8-K on August 14, 2024, reporting on other events and financial statements. The filing details various debt issuances, including $1.625 billion in notes due June 2, 2026, and $1.125 billion in notes due 2051. These issuances are part of the company's ongoing financing activities.

Why It Matters

This filing indicates Eli Lilly is actively managing its capital structure through significant debt offerings, which could impact its financial leverage and future investment capacity.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of debt issuance and does not indicate any unusual or negative events for the company.

Key Numbers

Key Players & Entities

FAQ

What is the total principal amount of debt issued in this filing?

The filing details multiple debt issuances, including $1.625 billion in notes due June 2, 2026, and $1.125 billion in notes due 2051, among others.

What is the maturity date for the $1.625 billion notes?

The $1.625 billion in notes are due on June 2, 2026.

What is the maturity date for the $1.125 billion notes?

The $1.125 billion in notes are due in 2051.

What is the filing date of this 8-K?

This 8-K filing was made on August 14, 2024.

What is the primary purpose of this 8-K filing?

This 8-K filing is to report on other events and financial statements, specifically detailing various debt issuances by Eli Lilly and Company.

From the Filing

0001193125-24-200435.txt : 20240814 0001193125-24-200435.hdr.sgml : 20240814 20240814122703 ACCESSION NUMBER: 0001193125-24-200435 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 22 CONFORMED PERIOD OF REPORT: 20240812 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240814 DATE AS OF CHANGE: 20240814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 241205794 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 8-K 1 d876011d8k.htm 8-K 8-K ELI LILLY & Co false 0000059478 0000059478 2024-08-12 2024-08-12 0000059478 us-gaap:CommonClassAMember 2024-08-12 2024-08-12 0000059478 lly:A718NotesDueJune12025Member 2024-08-12 2024-08-12 0000059478 lly:A1.625NotesDueJune22026Member 2024-08-12 2024-08-12 0000059478 lly:A2.125NotesDueJune32030Member 2024-08-12 2024-08-12 0000059478 lly:A625NotesDue2031Member 2024-08-12 2024-08-12 0000059478 lly:A500NotesDue2033Member 2024-08-12 2024-08-12 0000059478 lly:A6.77NotesDueJanuary12036Member 2024-08-12 2024-08-12 0000059478 lly:A1625NotesDue2043Member 2024-08-12 2024-08-12 0000059478 lly:A1700NotesDue2049Member 2024-08-12 2024-08-12 0000059478 lly:A1125NotesDue2051Member 2024-08-12 2024-08-12 0000059478 lly:A1375NotesDue2061Member 2024-08-12 2024-08-12     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): August 12, 2024     ELI LILLY AND COMPANY (Exact Name of Registrant as Specified in its Charter)       Indiana   001-06351   35-0470950 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.) Lilly Corporate Center Indianapolis , Indiana     46285 (Address of Principal Executive Offices)     (Zip Code) Registrant’s Telephone Number, Including Area Code: (317) 276-2000 Not Applicable (Former Name or Former Address, if Changed Since Last Report.)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2.):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock (no par value)   LLY   New York Stock Exchange 7 1/8% Notes due 2025   LLY25   New York Stock Exchange 1.625% Notes due 2026   LLY26   New York Stock Exchange 2.125% Notes due 2030   LLY30   New York Stock Exchange 0.625% Notes due 2031   LLY31   New York Stock Exchange 0.500% Notes due 2033   LLY33   New York Stock Exchange 6.77% Notes due 2036   LLY36   New York Stock Exchange 1.625% Notes du

View on Read The Filing